284 related articles for article (PubMed ID: 26497569)
1. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.
Bauer J; Ozden O; Akagi N; Carroll T; Principe DR; Staudacher JJ; Spehlmann ME; Eckmann L; Grippo PJ; Jung B
Mol Cancer; 2015 Oct; 14():182. PubMed ID: 26497569
[TBL] [Abstract][Full Text] [Related]
2. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway.
Jana A; Krett NL; Guzman G; Khalid A; Ozden O; Staudacher JJ; Bauer J; Baik SH; Carroll T; Yazici C; Jung B
Oncotarget; 2017 Jun; 8(23):37377-37393. PubMed ID: 28418896
[TBL] [Abstract][Full Text] [Related]
3. Effects of activin and TGFβ on p21 in colon cancer.
Bauer J; Sporn JC; Cabral J; Gomez J; Jung B
PLoS One; 2012; 7(6):e39381. PubMed ID: 22761777
[TBL] [Abstract][Full Text] [Related]
4. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
[TBL] [Abstract][Full Text] [Related]
5. TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function.
Principe DR; Diaz AM; Torres C; Mangan RJ; DeCant B; McKinney R; Tsao MS; Lowy A; Munshi HG; Jung B; Grippo PJ
Oncogene; 2017 Jul; 36(30):4336-4348. PubMed ID: 28368414
[TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.
Liu XQ; Rajput A; Geng L; Ongchin M; Chaudhuri A; Wang J
J Biol Chem; 2011 May; 286(18):16082-90. PubMed ID: 21454688
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
[TBL] [Abstract][Full Text] [Related]
8. Smad4 inactivation promotes malignancy and drug resistance of colon cancer.
Papageorgis P; Cheng K; Ozturk S; Gong Y; Lambert AW; Abdolmaleky HM; Zhou JR; Thiagalingam S
Cancer Res; 2011 Feb; 71(3):998-1008. PubMed ID: 21245094
[TBL] [Abstract][Full Text] [Related]
9. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
Renlund N; O'Neill FH; Zhang L; Sidis Y; Teixeira J
J Endocrinol; 2007 Oct; 195(1):95-103. PubMed ID: 17911401
[TBL] [Abstract][Full Text] [Related]
10. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
12. Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells.
Khalkhali-Ellis Z; Kirschmann DA; Seftor EA; Gilgur A; Bodenstine TM; Hinck AP; Hendrix MJ
Int J Cancer; 2015 Mar; 136(5):E242-51. PubMed ID: 25204799
[TBL] [Abstract][Full Text] [Related]
13. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus‑mediated knockdown of activin A receptor type 2A attenuates immune‑induced hepatic fibrosis in mice and inhibits interleukin‑17‑induced activation of primary hepatic stellate cells.
Zhang H; Ju B; Nie Y; Song B; Xu Y; Gao P
Int J Mol Med; 2018 Jul; 42(1):279-289. PubMed ID: 29620144
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.
Wang D; Nakayama M; Hong CP; Oshima H; Oshima M
Cancer Res; 2024 Jan; 84(1):56-68. PubMed ID: 37851521
[TBL] [Abstract][Full Text] [Related]
17. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
[TBL] [Abstract][Full Text] [Related]
18. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation.
Desgrosellier JS; Mundell NA; McDonnell MA; Moses HL; Barnett JV
Dev Biol; 2005 Apr; 280(1):201-10. PubMed ID: 15766759
[TBL] [Abstract][Full Text] [Related]
19. Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.
Refaat B; Zekri J; Aslam A; Ahmad J; Baghdadi MA; Meliti A; Idris S; Sultan S; Alardati H; Saimeh HA; Alsaegh A; Alhadrami M; Hamid T; Naeem ME; Elsamany SA
Pathol Oncol Res; 2021; 27():1610032. PubMed ID: 34867090
[TBL] [Abstract][Full Text] [Related]
20. Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability.
Suszko MI; Woodruff TK
J Mol Endocrinol; 2006 Jun; 36(3):591-600. PubMed ID: 16720726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
